阿替利珠单抗: 一种PDL1抑制剂药物,由Genentech, Inc. (Genentech, Inc.)公司最早进行研发,目前全球最高研发状态为批准上市,作用机制: PDL1抑制剂(程序性死亡配体1抑制剂),治疗领域: 肿瘤,消化系统疾病,呼吸系统疾病,在研适应症: 晚期非小细胞肺癌,乳腺癌,肺泡软组织肉
A human hepatoma cell line (Huh7) was transfected with a plasmid containing an HBV head-to-tail dimer using Fugene 6 reagent. We also cultured a further HepG2 cell line (AD38) that produces full infectious virus under the control of a tetracycline (Tet)-responsive promoter. HBV-DNA and ...